Broad Spectrum Distillate
CBD Isolate
CBG Isolate
Water Soluble CBD
Back to news
2. December 2020
Canada Corporate News Hemp News Production

Tritium 3H Brings Arcadia’s GoodHemp to Canada

Tritium 3H has signed a distribution agreement with Arcadia Biosciences (Nasdaq: RKDA) that will see the company distribute Arcadia’s GoodHemp seed varieties and genetics in Canada once they have been certified by the Association of Official Seed Certifying Agencies and Health Canada.

Canadian hemp seed company Tritium 3H (T3H) specialises in hemp field testing, certified seed production, commercialization and distribution of industrial hemp varieties for the Canadian market.

Arcadia’s GoodHemp seed catalog has been developed to deliver genetically superior hemp seeds, transplants and extracts, applying the company’s proprietary crop innovation technology, ArcaTech™, to an emerging crop.

T3H will look to introduce Arcadia’s GoodHemp seed varieties and genetics to its current portfolio as soon as the necessary approvals have been obtained. The initial varieties distributed will include:

  • Umpqua: CBD dominant, early photoperiod variety for both the smokable and CBD extraction markets. According to Arcadia the strain provides a unique terpene profile.
  • Rogue: CBD dominant, high yielding intermediate photoperiod variety for the CBD extraction markets.
  • Santiam: CBD dominant, early photoperiod variety with exceptional utility in northern latitudes for both the smokable and CBD extraction markets.

Arcadia CEO Matt Plavan commented on the agreement, “This agreement solidifies our plans to accelerate the commercialization of Arcadia’s hemp genetics internationally and affirms market demand for our portfolio of superior GoodHemp varieties. We’re proud to partner with a well-respected distributor like Tritium 3H to bring our CBD dominant, short day varieties to Canada’s industrial hemp growers.”

Our GoodHemp varieties were field-tested extensively in regional and national trials by the T3H and Arcadia teams. Working closely with T3H, we expect AOSCA certification in mid-December, Health Canada certification in February and significant commercial sales in the spring prior to the planting season.” continues Plavan.

Since launching its hemp operations in February 2019, Arcadia has been rapid-prototyping novel non-GM hemp varieties that target quality and performance characteristics highly desired by growers to overcome their greatest challenges – working directly with them in field deployment and monitoring to accelerate their speed to success.

Jayme Hunter, CEO of T3H said, “We’re pleased to add Arcadia’s high CBD, early maturing varieties to our portfolio. They’ve performed extremely well in our field trials allowing us to offer field proven, feminized, and compliant hemp genetics appropriate for all of Canada’s unique climatic regions. Arcadia’s genetics will provide market leading value to Canadian industrial hemp growers.”